|
1
|
Takanen S, Bangrazi C, Graziano V, Parisi
A, Resuli B, Simione L, Caiazzo R, Raffetto N and Tombolini V:
Number of mediastinal lymph nodes as a prognostic factor in PN2 non
small cell lung cancer: A single centre experience and review of
the literature. Asian Pac J Cancer Prev. 15:7559–7562. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tarone RE: On the International Agency for
Research on Cancer classification of glyphosate as a probable human
carcinogen. Eur J Cancer Prev. Nov 8–2017.(Epub ahead of
print).
|
|
3
|
Parsons A, Daley A, Begh R and Aveyard P:
Influence of smoking cessation after diagnosis of early stage lung
cancer on prognosis: Systematic review of observational studies
with meta-analysis. BMJ. 340:b55692010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer Clin. 61:69–90.
2011. View Article : Google Scholar
|
|
5
|
Fernandes AT, Mitra N, Xanthopoulos E,
Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L and Rengan R:
The impact of extent and location of mediastinal lymph node
involvement on survival in Stage III non-small cell lung cancer
patients treated with definitive radiotherapy. Int J Radiat Oncol
Biol Phys. 83:340–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shikazono N, Noguchi M, Fujii K,
Urushibara A and Yokoya A: The yield, processing, and biological
consequences of clustered DNA damage induced by ionizing radiation.
J Radiat Res. 50:27–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Greenstein JP: Biochemistry of cancer. New
York: Academic Press; 1954
|
|
8
|
Nakashima RA, Paggi MG and Pedersen PL:
Contributions of glycolysis and oxidative phosphorylation to
adenosine 5′-triphosphate production in AS-30D hepatoma cells.
Cancer Res. 44:5702–5706. 1984.PubMed/NCBI
|
|
9
|
Medes G, Thomas A and Weinhouse S:
Metabolism of neoplastic tissue. IV. A study of lipid synthesis in
neoplastic tissue slices in vitro. Cancer Res. 13:27–29.
1953.PubMed/NCBI
|
|
10
|
Chung YW, Han DS, Park YK, Son BK, Paik
CH, Lee HL, Jeon YC and Sohn JH: Association of obesity, serum
glucose and lipids with the risk of advanced colorectal adenoma and
cancer: a case-control study in Korea. Dig Liver Dis. 38:668–672.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Williams RR, Shorlie PD and Feinleib M:
Cancer incidence by levels of cholesterol. JAMA. 245:247–25234.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Liu JY, Wu X and Zhang JT:
Biochemistry, molecular biology, and pharmacology of fatty acid
synthase, an emerging therapeutic target and diagnosis/prognosis
marker. Int J Biochem Mol Biol. 1:69–89. 2010.PubMed/NCBI
|
|
13
|
Khan A, Aljarbou AN, Aldebasi YH, Faisal
SM and Khan MA: Resveratro suppresses the proliferation of breast
cancer cells by inhibiting fatty acid synthase signaling pathway.
Cancer Epidemiol. 38:765–772. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang B, Li EH, Lu YY, Jiang Q, Cui D,
Jing YF and Xia SJ: Inhibition of fatty acid synthase supresses
P-akt and induces apoptosis in bladder cancer. Urology.
80:484.e9–e15
|
|
15
|
Kao YC, Lee SW, Lin LC, Chen LT, Hsing CH,
Hsu HP, Huang HY, Shiue YL, Chen TJ and Li CF: Fatty acid synthase
overexpression confers an independent prognosticator and associates
with radiation resistance in nasopharyngeal carcinoma. Tumor Biol.
34:759–768. 2013. View Article : Google Scholar
|
|
16
|
Zhou Y, Niu C, Li Y, Gao B, Zheng J, Guo X
and Ma W: Fatty acid synthase expression and esophageal cancer. Mol
Biol Rep. 39:9733–9739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Y, Liu H, Li Z, Zhao Z, Yip-Schneider
M, Fan Q, Schmidt CM, Chiorean EG, Xie J, Cheng L, et al: Role of
fatty acid synthase in gemcitabin and radiation resistance of
pancreatic cancer. Int J Biochem Mol Biol. 2:89–98. 2011.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer. Nat Rev Cancer.
7:763–77. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shaw RJ: Glucose metabolism and cancer.
Curr Opin Cell Biol. 18:598–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuhajda FP: Fatty-acid Synthase and human
cancer: New perspectives on its role in tumor biology. Nutrition.
16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith S, Witkowski A and Joshi AK:
Structural and functional organization of the animal fatty acid
synthase. Prog Lipid Res. 42:289–317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pizer ES, Thupari J, Han WF, Pinn ML,
Chrest FJ, Frehywot GL, Townsend CA and Kuhajda FP:
Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced
by fatty-acid synthase inhibition in human breast cancer cells and
xenografts. Cancer Res. 60:213–218. 2000.PubMed/NCBI
|
|
24
|
De Schrijver E, Brusselmans K, Heyns W,
Verhoeven G and Swinnen JV: RNA interference-mediated silencing of
the fatty acid synthase gene attenuates growth and induces
morphological changes and apoptosis of LNCaP prostate cancer cells.
Cancer Res. 63:3799–3804. 2003.PubMed/NCBI
|
|
25
|
Yoshii Y, Furukawa T, Oyama N, Hasegawa Y,
Kiyono Y, Nishii R, Waki A, Tsuji AB, Sogawa C, Wakizaka H, et al:
Fatty acid synthase is a key target in multiple essential tumor
functions of prostate cancer: Uptake of radiolabeled acetate as a
predictor of the targeted therapy outcome. PLoS One. 8:e645702013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Wu X, Dong Z, Luo Z, Zhao Z, Xu Y
and Zhang JT: Fatty acid synthase causes drug resistance by
inhibiting TNF-α and ceramide production. J Lipid Res. 54:776–785.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yanold J: Molecular aspects of cellular
responses to radiotherapy. Radiothery Oncol. 44:1–7. 1997.
View Article : Google Scholar
|
|
28
|
Thompson LH: Evidence that mammalian cells
possess homologous recombinational repair pathways. Mutat Res.
363:77–88. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bertolini LR, Bertolini M, Anderson GB,
Maga EA, Madden KR and Murray JD: Transient depletion of Ku70 and
Xrcc4 by RNAi as a means to manipulate the non-homologous
end-joining pathway. J Biotechnol. 128:246–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hamer G, Roepers Gajadien HL, Van
Duyn-Goedhart A, Gademan IS, Kal HB, van Buul PP, Ashley T and de
Rooij DG: Function of DNA-protein kinase catalytic subunit during
the early meiotic prophase without Ku70 and Ku86. Biol Reprod.
68:717–721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeggo PA: Identification of genes involved
in repair of DNA doublestrand breaks in mammary cells. Radiat Res.
150:580–591. 1998. View
Article : Google Scholar
|
|
32
|
Yaneva M, Kowalewski T and Lieber MR:
Interaction of DNA-dependent protein kinase with DNA and with Ku:
Biochemical and atomic force microscopy. EMBO J. 16:5098–5112.
1997. View Article : Google Scholar : PubMed/NCBI
|
